Screening of a diversity library of 240 000 small molecules against SARS-CoV-2

This report details an antiviral screen of 240 000 small molecules against SARS-CoV-2 which were used for early hit-to-lead activities.本报告详述了以新型冠状病毒（SARS-CoV-2）为靶标的240000种小分子化合物抗病毒筛选研究，相关化合物可用于早期苗头化合物到先导化合物（hit-to-lead）的研发活动。